ScreenerHero
NHINational Health Investors, Inc.
NYSE · US · Real Estate · REIT - Healthcare Facilities · nhireit.com
76.26USD-1.73%Mkt Cap: 3.70B $P/E: 24.60

National Health Investors, Inc. is a self-managed real estate investment trust specializing in sale-leaseback, joint venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical f…

Industry Peers

REIT - Healthcare Facilities
Screen all
vs REIT - Healthcare Facilities
P/E
Avg
P/B
Pricier
Div Yield
Higher
1M Perf
Avg
WELL
Welltower Inc.
$160.22BUSDP/E 109.6
VTR
Ventas, Inc.
$43.17BUSDP/E 161.5
OHI
Omega Healthcare Investors, Inc.
$14.87BUSDP/E 23.0
DOC
Healthpeak Properties, Inc.
$14.75BUSDP/E 66.9
CTRE
CareTrust REIT, Inc.
$9.53BUSDP/E 25.5
HR
Healthcare Realty Trust Incorporated
$7.07BUSD
AED
Aedifica NV/SA
$6.41BUSDP/E 6.1
CSH-UN
Chartwell Retirement Residences
$5.30BUSDP/E Infinity
SBRA
Sabra Health Care REIT, Inc.
$4.92BUSDP/E 31.0
COFB
Cofinimmo SA
$3.43BUSDP/E 15.5
PHP
Primary Health Properties Plc
$2.70BUSDP/E 13.7
MPT
Medical Properties Trust, Inc.
$2.76BUSD
DHC
Diversified Healthcare Trust
$2.25BUSD
LTC
LTC Properties, Inc.
$1.97BUSDP/E 15.1
SILA
Sila Realty Trust, Inc.
$1.68BUSDP/E 44.6
NHP
National Healthcare Properties, Inc.
$1.08BUSD
CPINV
Care Property Invest NV
$578.96MUSDP/E 8.3
UHT
Universal Health Realty Income Trust
$608.58MUSDP/E 34.3
CHCT
Community Healthcare Trust Incorporated
$522.29MUSDP/E 152.3
XRN
Chiron Real Estate Inc.
$496.57MUSD
STRW
Strawberry Fields REIT, Inc.
$184.62MUSDP/E 21.5
Indicators:|

Key Statistics

Company
Market Cap3.70B $
Enterprise Value5.12B $
Revenue (TTM)404.71M $
Gross Profit364.65M $
Net Income (TTM)142.18M $
Revenue/Share8.516 USD
Last Price76.26 USD
Fiscal Year EndDec 2025
MR QuarterMar 2021
Employees32
CountryUS
SectorReal Estate
IndustryREIT - Healthcare Facilities
ISINUS63633D1046
Valuation
P/E (Trailing)24.60
P/E (Forward)22.10
PEG4.76
EV/EBITDA17.95
EV/Revenue12.65
P/S9.13
P/B2.44
EPS (TTM)3.10
EPS (Forward)3.45
52W Range
67.9535% of range91.38
52W High91.38 USD
52W Low67.95 USD
Profitability
Gross Margin97.08%
Oper. Margin61.34%
EBITDA Margin70.46%
Profit Margin37.85%
ROE9.34%
ROA5.08%
Growth
Revenue Growth-2.60%
Earnings Growth-43.00%
Cash Flow & Leverage
Operating CF236.56M $
CapEx (TTM)—
FCF Margin51.38%
FCF Yield5.63%
Net Debt1.41B $
Net Debt/EBITDA4.95
Balance Sheet
Debt/Equity0.76
Current Ratio0.60
Quick Ratio0.55
Book Value/Sh31.26 USD
Cash/Share2.339 USD
Dividends
Fwd Div Rate3.680 USD
Trail. Div Rate3.660 USD
Div. Yield4.83%
5Y Avg Yield5.85%
Payout Ratio118.06%
Ex-Div DateJun 30, 2026
Pay DateAug 7, 2026
Analyst Consensus
Rating1.8 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)82.88 USD
Upside (mean)+8.7%
Target Range74.00 USD – 91.00 USD
$74.00+8.7% to mean$91.00
# Analysts8
Ownership
Shares Out.48.47M
Float47.30M
Insiders2.41%
Institutions75.37%
Short Interest
Short Ratio4.3d
Short % Float3.91%
Short % Out.3.81%
Shares Short1.85M
Short (prev mo.)1.88M
Technical
SMA 5074.81 (+1.9%)
SMA 20078.82 (-3.3%)
Beta0.55
S&P 52W Chg20.05%
Avg Vol (30d)422.04K
Avg Vol (10d)1.52M
Technical Indicators
RSI (14)58.0
MACD0.4716
MACD Signal-0.4424
MACD Hist.+0.9140
BB Upper77.92 USD
BB Middle72.42 USD
BB Lower66.92 USD
BB Width15.19%
ATR (14)1.902 USD
Vol Ratio (20d)1.38x